Selegiline in Parkinson's disease - No neuroprotective effect: Increased mortality

被引：29

作者：

Calne, DB

机构：

来源：

BMJ-BRITISH MEDICAL JOURNAL | 1995年 / 311卷 / 7020期

关键词：

D O I：

10.1136/bmj.311.7020.1583

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1583 / 1584

页数：2

共 13 条

[1] SELEGILINE IN DENOVO PARKINSONIAN-PATIENTS - THE FRENCH SELEGILINE MULTICENTER TRIAL (FSMT) [J].

ALLAIN, H ;

COUGNARD, J ;

NEUKIRCH, HC .

ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 :73-78

[2] INCREASED LIFE EXPECTANCY RESULTING FROM ADDITION OF L-DEPRENYL TO MADOPAR TREATMENT IN PARKINSONS-DISEASE - A LONGTERM STUDY [J].

BIRKMAYER, W ;

KNOLL, J ;

RIEDERER, P ;

YOUDIM, MBH ;

HARS, V ;

MARTON, J .

JOURNAL OF NEURAL TRANSMISSION, 1985, 64 (02) :113-127

[3] COMPARATIVE-STUDY OF SELEGILINE PLUS L-DOPA-CARBIDOPA VERSUS L-DOPA-CARBIDOPA ALONE IN THE TREATMENT OF PARKINSONS-DISEASE [J].

BRANNAN, T ;

YAHR, MD .

ANNALS OF NEUROLOGY, 1995, 37 (01) :95-98

[4] THE FREE-RADICAL HYPOTHESIS IN IDIOPATHIC PARKINSONISM - EVIDENCE AGAINST IT [J].

CALNE, DB .

ANNALS OF NEUROLOGY, 1992, 32 (06) :799-803

[5] SELEGILINE AS AN ADJUNCT TO CONVENTIONAL LEVODOPA THERAPY IN PARKINSONS-DISEASE - EXPERIENCE WITH THIS TYPE-B MONOAMINE-OXIDASE INHIBITOR IN 200 PATIENTS [J].

ELIZAN, TS ;

YAHR, MD ;

MOROS, DA ;

MENDOZA, MR ;

PANG, S ;

BODIAN, CA .

ARCHIVES OF NEUROLOGY, 1989, 46 (12) :1280-1283

[6] THE OXIDANT STRESS HYPOTHESIS IN PARKINSONS-DISEASE - EVIDENCE SUPPORTING IT [J].

FAHN, S ;

COHEN, G .

ANNALS OF NEUROLOGY, 1992, 32 (06) :804-812

[7] SELEGILINE AS INITIAL TREATMENT IN DENOVO PARKINSONIAN-PATIENTS [J].

MYLLYLA, VV ;

SOTANIEMI, KA ;

VUORINEN, JA ;

HEINONEN, EH .

NEUROLOGY, 1992, 42 (02) :339-343

[8]

OLANOW CW, IN PRESS ANN NEUROL

[9] THE ANTIPARKINSON EFFICACY OF DEPRENYL DERIVES FROM TRANSIENT IMPROVEMENT THAT IS LIKELY TO BE SYMPTOMATIC [J].

SCHULZER, M ;

MAK, E ;

CALNE, DB .

ANNALS OF NEUROLOGY, 1992, 32 (06) :795-798

[10]

SHOULSON I, 1989, NEW ENGL J MED, V321, P1364

← 1 2 →